📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jcpo.2022.100342

PubMed Identifier: 35718327

Publication URI: http://europepmc.org/abstract/MED/35718327

Type: Journal Article/Review

Volume: 33

Parent Publication: Journal of cancer policy

ISSN: 2213-5383